Glucotrack (GCTK) Capital Expenditures Growth (1y) (2011 - 2025)
Glucotrack (GCTK) Capital Expenditures Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 125.91 Bn | 120.70 Bn | 1.96 Bn | 17.46% |
| 2 | Becton Dickinson | 44.75 Bn | 43.93 Bn | 2.15 Bn | 9.65% |
| 3 | Alcon | 32.94 Bn | 31.28 Bn | 1.53 Bn | - |
| 4 | Medline | 32.84 Bn | 30.60 Bn | 1.84 Bn | -2.04% |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | 61.83% |
| 6 | West Pharmaceutical Services | 23.60 Bn | 23.16 Bn | 329.20 Mn | -42.55% |
| 7 | Solventum | 14.01 Bn | 13.45 Bn | 1.10 Bn | -22.94% |
| 8 | Cooper Companies | 13.76 Bn | 13.62 Bn | 735.40 Mn | 10.63% |
| 9 | Align Technology | 12.04 Bn | 10.98 Bn | 736.59 Mn | 21.73% |
| 10 | Glucotrack | 186,017.65 | -7.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 103.03% |
| Mar 31, 2025 | -84.75% |
| Dec 31, 2022 | -175.00% |
| Dec 31, 2021 | -42.86% |
| Dec 31, 2020 | 1,469.51% |
| Sep 30, 2020 | 145.23% |
| Mar 31, 2020 | 135.18% |
| Dec 31, 2019 | -76.10% |
| Sep 30, 2019 | 693.53% |
| Jun 30, 2019 | 260.35% |
| Mar 31, 2019 | 585.07% |
| Sep 30, 2018 | -89.10% |
| Jun 30, 2018 | -70.91% |
| Mar 31, 2018 | -36.97% |
| Sep 30, 2017 | -49.37% |
| Jun 30, 2017 | -84.97% |
| Mar 31, 2017 | -93.83% |
| Sep 30, 2016 | -61.92% |
| Jun 30, 2016 | 230.66% |
| Mar 31, 2016 | 97.89% |